(via TheNewswire)
![Ocumetics Technology Corp.](https://tnw-c.thenewswire.com/data/tnw/clients/logos/1AdyFnGxm.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/facebook.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/youTube.png)
The preclinical studies for the Bionic Lens, consisting of the lens retainer and the lens itself, commenced on
Stage | Description | Status | Expected completion |
1 | Test the Bionic Lens retainer for structural integrity and ease of insertion by the surgeon. | Commenced Oct 22/21. Analysis completed in | Study completed Oct/21. Design improvements completed Dec/21. |
2 | Test the Bionic lens retainer with a standard lens used in a typical cataract procedure. | Scheduled to begin | Research report expected June/22. |
3 | Test theBionic Lens retainer and the Bionic Lens optic element together. | Scheduled to begin | Research report expected June/22. |
“Our research team has planned three stages of preclinical studies to test the two components of the Bionic Lens technology - the retainer and the optic element,” said Dr.
“We are pleased with the learnings obtained from the first stage of our preclinical studies,” adds
Successful preclinical studies will be followed by Phase 1 human clinical trials, starting with a planned Proof-of-Concept study in the Fall of 2022.
About
FOR FURTHER INFORMATION, PLEASE CONTACT:
Dr.
President and CEO
(604) 832-6052
Neither the
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the commencement, timing and scope of the clinical trial program outlined above and that it will be conducted as expected. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include but are not limited to: operational matters, historical trends, current conditions and expected future developments, access to financing as well as other considerations that are believed to be appropriate in the circumstances. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Copyright (c) 2022 TheNewswire - All rights reserved.
Copyright (c) 2022 TheNewswire - All rights reserved., source